Skip to content

4563.T

AnGes,Inc.

グロース · 医薬品 · 医薬品 · JP

JPY 39.00
+0.00%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue908.0M874.0M643.0M152.0M67.0M
Cost of Revenue562.0M553.7M395.9M133.5M93.9M
Gross Profit345.9M320.3M247.1M18.5M(26.9M)
Operating Expenses
R&D Expense
SG&A Expense2.0B1.9B5.6B5.8B5.3B
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses2.0B1.9B5.6B5.8B5.3B
Cost and Expenses6.3B6.0B9.8B12.1B16.4B
Operating Income (EBIT)(5.4B)(5.1B)(9.1B)(12.0B)(16.3B)
Non-Operating
Interest Income17.6M14.9M4.4M8.4M1.8M
Interest Expense
Net Interest Income
Other Non-Op Income/Expense225.1M(143.4M)1.6B6.3B1.7B
Non-Operating Income (excl Interest)473.3M114.5M1.6B6.3B1.7B
EBT (Pre-Tax Income)(5.1B)(5.2B)(27.6B)(7.5B)(14.7B)
Income Tax Expense(151.1M)(113.3M)485.3M(33.8M)(2.2M)
Bottom Line
Net Income(5.0B)(5.1B)(28.1B)(7.4B)(14.7B)
Earnings from Cont. Ops
Earnings from Discont. Ops
Bottom Line Net Income(5.0B)(5.1B)(28.1B)(7.4B)(14.7B)
Per Share
Basic EPS(¥14)(¥14)(¥120)(¥39)(¥94)
Diluted EPS(¥14)
Revenue Per Share¥2¥2¥3¥1¥0
Shares
Basic Shares Outstanding395.2M354.8M235.3M189.3M156.1M
Diluted Shares Outstanding
Profitability Metrics
EBITDA(2.7B)(5.1B)(9.1B)(11.9B)(16.3B)
D&A53.8M53.8M48.9M27.9M18.2M
EBIT(5.4B)(5.1B)(9.1B)(12.0B)(16.3B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026